Amicus Therapeutics Securities Litigation
In re: Amicus Therapeutics, Inc. Securities Litigation, No. 3:15-cv-07350 (D. N.J.)
On April 14, 2017, Block & Leviton LLP filed for preliminary approval of a $3.75 million settlement in this case. That motion is currently pending before the Court. Check back for additional updates.
- Amended Complaint (July 11, 2016)
- Memorandum in Support of Motion for Preliminary Approval of Settlement (April 14, 2017)
- Settlement Agreement (with exhibits) (April 14, 2017)